Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
Sign Up to like & getrecommendations! Published in 2018 at "Current Oncology Reports"
DOI: 10.1007/s11912-018-0711-0
Abstract: Purpose of ReviewHere, we will review and summarize the current status and emerging data supporting the use of trimodality therapy as an alternative to cystectomy for patients with muscle-invasive bladder cancer.Recent FindingsThere are no randomized-controlled… read more here.
Keywords: bladder; trimodality therapy; preserving trimodality; muscle invasive ... See more keywords
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2017 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2017.07.009
Abstract: Purpose Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature suggests that surgery after… read more here.
Keywords: trimodality therapy; surgery; stage iii; definitive doses ... See more keywords
Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of geriatric oncology"
DOI: 10.1016/j.jgo.2017.08.010
Abstract: OBJECTIVES The aim of this study was to characterize outcomes associated with neoadjuvant chemoradiation prior to esophagectomy, compared to esophagectomy alone, in older patients with esophageal cancer. MATERIALS AND METHODS We conducted an observational cohort… read more here.
Keywords: esophageal cancer; trimodality therapy; neoadjuvant chemoradiation; chemoradiation ... See more keywords
Trimodality therapy for bladder cancer: modern management and future directions
Sign Up to like & getrecommendations! Published in 2019 at "Current Opinion in Urology"
DOI: 10.1097/mou.0000000000000601
Abstract: Purpose of review This review examines both trimodality therapy (TMT) in the definitive management of bladder cancer as well as the use of adjuvant radiotherapy for bladder cancer with a specific focus on publications from… read more here.
Keywords: trimodality therapy; bladder; bladder cancer; management ... See more keywords
Survival Following Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Surgery"
DOI: 10.1097/sla.0000000000004638
Abstract: OBJECTIVE To evaluate whether pCR exclusively defines major pathologic response to treatment with improved survival. SUMMARY BACKGROUND DATA pCR after trimodality therapy for EAC is infrequent but associated with improved prognosis. Yet most clinical trials… read more here.
Keywords: trimodality therapy; survival; pathologic response;
Abstract 951: Clinical model for predicting pathological complete response in patients with esophageal and gastroesophageal junction adenocarcinoma after trimodality therapy
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-951
Abstract: Background: Approximately 25% of patients with esophageal adenocarcinoma achieve pathological complete response (pathCR) after chemoradiotherapy with following surgery (trimodality therapy). The prediction for pathCR would provide an important guidance for decision making regarding surgical strategy.… read more here.
Keywords: pathcr; cancer; model; trimodality therapy ... See more keywords
Systemic Immune-Inflammatory Index Association with Survival in Patients Undergoing Trimodality Therapy for Lung Cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Oncology"
DOI: 10.1159/000520989
Abstract: PURPOSE The systemic immune-inflammation index (SII) is correlated with patient survival in various solid malignancies including non-small cell lung cancer (NSCLC). However, limited information is available on the prognostic implication of SII in patients undergoing… read more here.
Keywords: trimodality therapy; therapy; survival; lung cancer ... See more keywords
Recurrence patterns in esophageal cancer patients undergoing curative trimodality therapy.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.4_suppl.195
Abstract: 195Background: To document pattern of recurrence and its relationship to the radiation treatment volume in esophageal cancer patients treated with trimodality therapy. Methods: Patients with adenoc... read more here.
Keywords: esophageal cancer; cancer patients; trimodality therapy; recurrence ... See more keywords
ASO Author Reflections: Predicting Early Recurrence After Trimodality Therapy for Esophageal Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-018-7016-2
Abstract: ASO Author Reflections is a brief invited commentary on the article “Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma”, Ann Surg Oncol. 2018;25:1598–1607. read more here.
Keywords: trimodality therapy; author reflections; esophageal adenocarcinoma; aso author ... See more keywords
‘CROSS’-ing into the ‘Real World’: a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Gastrointestinal Oncology"
DOI: 10.21037/jgo-22-633
Abstract: Background A standard of care for nonmetastatic esophageal cancer is trimodality therapy consisting of neoadjuvant chemoradiation and esophagectomy, with evidence for improved overall survival versus surgery alone in the ChemoRadiotherapy for Oesophageal cancer followed by… read more here.
Keywords: therapy; bimodality; bimodality therapy; cancer ... See more keywords
Adjuvant chemotherapy following trimodality therapy for esophageal carcinoma-Is the evidence sufficient?
Sign Up to like & getrecommendations! Published in 2017 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2017.09.68
Abstract: The preferred management of localized esophageal carcinoma consists of multi-modality therapy (chemotherapy, radiation, and surgery). The ideal timing, treatment sequence, and dose of therapy remain active areas of investigation and controversy. Following publication of favorable… read more here.
Keywords: chemotherapy; trimodality therapy; adjuvant chemotherapy; evidence ... See more keywords